SG11202112680XA - Rapid aneuploidy detection - Google Patents
Rapid aneuploidy detectionInfo
- Publication number
- SG11202112680XA SG11202112680XA SG11202112680XA SG11202112680XA SG11202112680XA SG 11202112680X A SG11202112680X A SG 11202112680XA SG 11202112680X A SG11202112680X A SG 11202112680XA SG 11202112680X A SG11202112680X A SG 11202112680XA SG 11202112680X A SG11202112680X A SG 11202112680XA
- Authority
- SG
- Singapore
- Prior art keywords
- aneuploidy detection
- rapid
- rapid aneuploidy
- detection
- aneuploidy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/16—Assays for determining copy number or wherein the copy number is of special importance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medical Informatics (AREA)
- Data Mining & Analysis (AREA)
- Theoretical Computer Science (AREA)
- Software Systems (AREA)
- Public Health (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Evolutionary Computation (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962849662P | 2019-05-17 | 2019-05-17 | |
| US201962905327P | 2019-09-24 | 2019-09-24 | |
| US202062971050P | 2020-02-06 | 2020-02-06 | |
| PCT/US2020/033209 WO2020236625A2 (en) | 2019-05-17 | 2020-05-15 | Rapid aneuploidy detection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202112680XA true SG11202112680XA (en) | 2021-12-30 |
Family
ID=71741878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202112680XA SG11202112680XA (en) | 2019-05-17 | 2020-05-15 | Rapid aneuploidy detection |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220259668A1 (en) |
| EP (1) | EP3969616A2 (en) |
| JP (1) | JP2022532761A (en) |
| KR (1) | KR20220021909A (en) |
| CN (1) | CN114207147A (en) |
| AU (1) | AU2020279106A1 (en) |
| BR (1) | BR112021023025A2 (en) |
| CA (1) | CA3140850A1 (en) |
| CL (1) | CL2021003030A1 (en) |
| CO (1) | CO2021017009A2 (en) |
| IL (1) | IL288081A (en) |
| MX (1) | MX2021013834A (en) |
| SG (1) | SG11202112680XA (en) |
| WO (1) | WO2020236625A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023239866A1 (en) * | 2022-06-10 | 2023-12-14 | The Johns Hopkins University | Methods for identifying cns cancer in a subject |
| CN114990202B (en) * | 2022-07-29 | 2022-09-30 | 普瑞基准科技（北京）有限公司 | Application of SNP (Single nucleotide polymorphism) locus in evaluation of genome abnormality and method for evaluating genome abnormality |
| KR102630597B1 (en) * | 2023-08-22 | 2024-01-29 | 주식회사 지놈인사이트테크놀로지 | Method and apparatus for detecting minimal residual disease using tumor information |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1712639T3 (en) | 2005-04-06 | 2009-02-27 | Maurice Stroun | Method for the diagnosis of cancer by detecting circulating DNA and RNA |
| CN104350158A (en) * | 2012-03-26 | 2015-02-11 | 约翰霍普金斯大学 | Rapid aneuploidy detection |
| JP6929778B2 (en) * | 2015-01-15 | 2021-09-01 | グッド スタート ジェネティクス， インコーポレイテッド | Quality control method using single nucleotide polymorphism in pre-implantation gene screening |
| MX2020001575A (en) | 2017-08-07 | 2020-11-18 | Univ Johns Hopkins | Methods and materials for assessing and treating cancer. |
-
2020
- 2020-05-15 AU AU2020279106A patent/AU2020279106A1/en active Pending
- 2020-05-15 EP EP20744188.2A patent/EP3969616A2/en active Pending
- 2020-05-15 JP JP2021568507A patent/JP2022532761A/en active Pending
- 2020-05-15 KR KR1020217037650A patent/KR20220021909A/en unknown
- 2020-05-15 CN CN202080051877.7A patent/CN114207147A/en active Pending
- 2020-05-15 MX MX2021013834A patent/MX2021013834A/en unknown
- 2020-05-15 WO PCT/US2020/033209 patent/WO2020236625A2/en active Application Filing
- 2020-05-15 SG SG11202112680XA patent/SG11202112680XA/en unknown
- 2020-05-15 BR BR112021023025A patent/BR112021023025A2/en unknown
- 2020-05-15 US US17/611,788 patent/US20220259668A1/en active Pending
- 2020-05-15 CA CA3140850A patent/CA3140850A1/en active Pending
-
2021
- 2021-11-14 IL IL288081A patent/IL288081A/en unknown
- 2021-11-17 CL CL2021003030A patent/CL2021003030A1/en unknown
- 2021-12-14 CO CONC2021/0017009A patent/CO2021017009A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20220259668A1 (en) | 2022-08-18 |
| MX2021013834A (en) | 2022-06-29 |
| KR20220021909A (en) | 2022-02-22 |
| CL2021003030A1 (en) | 2022-10-07 |
| WO2020236625A3 (en) | 2021-02-11 |
| BR112021023025A2 (en) | 2022-01-04 |
| WO2020236625A2 (en) | 2020-11-26 |
| CO2021017009A2 (en) | 2022-04-08 |
| JP2022532761A (en) | 2022-07-19 |
| CN114207147A (en) | 2022-03-18 |
| AU2020279106A1 (en) | 2021-12-09 |
| IL288081A (en) | 2022-01-01 |
| CA3140850A1 (en) | 2020-11-26 |
| EP3969616A2 (en) | 2022-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2606096B (en) | On-ear detection | |
| IL288081A (en) | Rapid aneuploidy detection | |
| GB201806762D0 (en) | Improved processes for performing direct detection | |
| GB201810483D0 (en) | Phishing detection | |
| IL279125A (en) | Detection method | |
| GB2588572B (en) | Transition Detection | |
| IL290969A (en) | Equi-probability defect detection | |
| GB201908045D0 (en) | Object analysis | |
| GB201907882D0 (en) | Methods | |
| SG11202113179WA (en) | Context detection | |
| IL277890B (en) | Methods for quantifying il-33 | |
| GB201915469D0 (en) | Cancer detection methods | |
| GB201916371D0 (en) | 3D object detection | |
| GB201913716D0 (en) | Methods | |
| GB201906705D0 (en) | Methods | |
| GB201820867D0 (en) | Detection method | |
| GB201919449D0 (en) | State detection | |
| GB201907157D0 (en) | Methods | |
| GB201903909D0 (en) | Methods | |
| GB201901817D0 (en) | Methods | |
| GB2596502B (en) | Crypto-jacking detection | |
| GB201906842D0 (en) | Detection methods | |
| GB2596002B (en) | Object analysis | |
| GB2585410B (en) | Analysis | |
| GB202104169D0 (en) | Detection methods |